According to developers, the Sputnik V vaccine is 95 percent effective according to a second interim analysis of clinical trial data.
Russia’s two-shot Sputnik V COVID-19 vaccine costs less than $ 20 per person in international markets and is free to Russian citizens, according to a statement on Sputnik V’s official Twitter account.
Kirill Dmitriev, head of Russia’s RDIF sovereign wealth fund, told Reuters Sputnik V on Tuesday that the price would be significantly lower than competitors with similar levels of effectiveness.
He spoke after RDIF and the Gamaleya National Center said new data from clinical trials based on 39 confirmed cases and 18,794 patients who received both shots showed 91.4 percent of Sputnik V on day 28 and was more than 95 percent effective on day 42.
The announcements come as several drug manufacturers reveal positive interim data in a scientific race to contain the global pandemic.
British drug giant AstraZeneca and Oxford University, which have pledged not to make a profit on the vaccine during the pandemic, have reached agreements with governments and international health organizations that put their costs at around $ 2.50 per dose.
Pfizer’s vaccine costs around $ 20 per dose, while Moderna’s one costs $ 15 to $ 25. This is based on agreements the companies have made to ship their vaccines to the US government.
The Russian drug is called Sputnik V after the Soviet-era satellite that sparked the space race, an allusion to the geopolitical significance of the project for Russian President Vladimir Putin.
No serious side effects were reported during the Phase 3 study of Sputnik V as of November 11, according to RDIF.
Some volunteers experienced minor short-term side effects such as injection site pain and flu-like symptoms such as fever, weakness, tiredness and headache.